Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 73%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is in a precarious position, with concerns about its ability to evolve in rapidly commoditizing markets and declining pricing power. However, its ubiquitous virtual care platform and ability to deliver whole-person care give it a unique advantage in the market, and its push towards whole-person health could provide a new source of revenue potential. The company's plans to mitigate gross margin pressures through operational cuts and growth could help restore its preeminence, but there is concern about the impact on key functions and pricing power. Their target price is $9 based on a 10x multiple of CY26E Integrated Care segment adjusted EBITDA and the potential for margin pressure suggests a lack of pricing power.

Bears say

Teladoc Health is a market leader in virtual healthcare solutions, with a platform that connects patients, providers, and healthcare systems. While the company has strong growth potential in areas such as its insurance offering and international expansion, its slower growth in its BetterHelp segment could hinder its overall enterprise success. Additionally, fluctuations in membership and impact of ACA subsidies expiration on Integrated Care revenue may cause volatility in growth. With a reasonable valuation and potential optionality, there may be signs of long-term growth upside, but lack of clarity on transitory factors warrants a cautious outlook.

Teladoc (TDOC) has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 73% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 15 analysts, Teladoc (TDOC) has a Hold consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.37, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.37, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.